Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
[1] Tirzepatide (Mounjaro, Zepbound) has a half-life of approximately 5 days, with elimination taking about 4-5 weeks after the last dose
In the weight management therapeutics domain, including obesity drugs, Ozempic and its related formulations represent about 65% of the segments total value
One real-world evidence study found that patients receiving GLP-1 receptor agonists had a higher risk of ulcerative colitis compared to those on DPP-4 inhibitors (a different diabetes drug class)
Sonobe H, Takeuchi T, Furihata M, Taguchi T, Kawai A, Ohjimi Y, et al
US$ 22.78
US$ 22.06
US$ 20.55
US$ 26.76
